Osteoarthritis Trial, Recruiting NCT07513415 Sponsor: Endovision Co., Ltd. Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07513415
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a man or woman aged 40 to 79 years old at the time of signing the consent form.
  • You have been diagnosed with knee osteoarthritis (a condition where the cartilage in the knee wears down) according to standard medical guidelines, either at or within 24 weeks before your first study visit.
  • You have had pain in your affected knee for at least 8 weeks.
  • An X-ray of your knee shows a moderate level of osteoarthritis severity (rated grade I, II, or III on a standard medical scale called the Kellgren-Lawrence scale) (confirm with trial site).
  • Your knee pain scores at least 40 mm out of 100 mm on a standard pain measurement scale when you put weight on it.
  • Your Body Mass Index (BMI — a measure of body weight relative to height) is below 35.
  • You are able to walk without a walking aid such as a cane or walker — or, if you have been regularly using one for at least 24 weeks before your first visit, you may still be able to participate using that same device throughout the trial.
  • You are willing to sign a consent form agreeing to take part in the trial.
  • You are able to understand the trial procedures and attend all required visits.

Who may not be able to join:

  • You have had surgery on the study knee (including keyhole or joint-cleaning surgery) within the 24 weeks before your first study visit.
  • You have had any arthroscopic (keyhole) treatment on the study knee within the 24 weeks before your first study visit.
  • Doctors feel you need surgery on the study knee right now.
  • Your study knee shows significant looseness or instability in the ligaments (the tissues that hold the joint together) on physical examination (confirm with trial site).
  • Your study knee has bone fractures or significant misalignment (such as being notably bow-legged or knock-kneed) that could interfere with the treatment.
  • Your knee pain appears to be coming from nearby joints (such as the hip) rather than, or in addition to, the knee itself, in a way that could make it hard to assess the knee pain.
  • You have certain other health conditions, including: rheumatoid arthritis, gout, fibromyalgia, psoriatic arthritis, joint infection, osteonecrosis, amyloidosis, serious liver, heart or kidney disease, a cancer diagnosis within the last 5 years, or a blood clotting disorder such as haemophilia (confirm with trial site for full list).
  • There is an active infection or inflammation in the study knee.
  • There is a large build-up of fluid in the study knee.
  • You have a skin condition or problem at the area of the study knee.
  • You have an allergy or sensitivity to products derived from pigs.
  • You have had an allergic reaction or bad reaction to any ingredients in the device being studied in this trial (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +82 10 9026 4802

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Endovision Co., Ltd.
Registry
ClinicalTrials.gov
Start date
4 February 2025
Est. completion
1 June 2027

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Change in knee pain measured by Visual Analog Scale (VAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov